Alpha Teknova (TKNO) Gross Margin (2020 - 2026)

Alpha Teknova's (TKNO) quarterly Gross Margin came in at 34.16% in Q1 2026, up 346.0% year-on-year from 7.66% in Q1 2025, and up 5.14% on a QoQ basis from 32.49% in Q4 2025.

Alpha Teknova (TKNO) Gross Margin (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Gross Margin data on file, last reported at 34.16% in Q1 2026.

  • On a quarterly basis, Gross Margin rose 346.0% year-over-year to 34.16% in Q1 2026; TTM through Mar 2026 was 34.01%, a 1302.0% increase from a year earlier, with the FY2025 full-year figure at 33.17%, up 1401.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 34.16%, up from 32.49% in the prior quarter.
  • Over the last five years, Gross Margin for TKNO reached as high as 47.99% in Q1 2022 and fell as low as 0.94% in Q3 2024.
  • Historically, Gross Margin has averaged 30.2% across 5 years, with a median of 30.67% in 2025.
  • Across the five-year window, Gross Margin tumbled 2659 bps in 2023 and surged 2973 bps in 2025, its largest moves.
  • Year by year, Gross Margin stood at 26.74% in 2022, then plunged by 37 bps to 16.97% in 2023, then jumped by 35 bps to 22.97% in 2024, then soared by 41 bps to 32.49% in 2025, then rose by 5 bps to 34.16% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 34.16% in Q1 2026, 32.49% in Q4 2025, and 30.67% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn 34.16%

Historic Data

Download Data
DateValue
Mar 31, 2026 34.16%
Dec 31, 2025 32.49%
Sep 30, 2025 30.67%
Jun 30, 2025 38.73%
Mar 31, 2025 30.70%
Dec 31, 2024 22.97%
Sep 30, 2024 0.94%
Jun 30, 2024 29.17%
Mar 31, 2024 23.78%
Dec 31, 2023 16.97%
Sep 30, 2023 18.02%
Jun 30, 2023 43.95%
Mar 31, 2023 26.57%
Dec 31, 2022 26.74%
Sep 30, 2022 44.61%
Jun 30, 2022 44.88%
Mar 31, 2022 47.99%
Dec 31, 2021 49.25%
Sep 30, 2021 45.39%
Jun 30, 2021 40.35%